TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy (Q36825602)
Jump to navigation
Jump to search
scientific article published on 22 April 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy |
scientific article published on 22 April 2016 |
Statements
1 reference
TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy (English)
1 reference
Elisabeth Ralfkiaer
1 reference
Fazila Asmar
1 reference
Kirsten Grønbæk
1 reference
Mia Seremet Girkov
1 reference
Anja Pedersen
1 reference
Helga D Munch-Petersen
1 reference
Steffen Heegaard
1 reference
Konstantinos Dimopoulos
1 reference
Aušrinė Areškevičiūtė
1 reference
Peter Brown
1 reference
Lene D Sjö
1 reference
Helle Broholm
1 reference
Lasse S Kristensen
1 reference
22 April 2016
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference